Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Novel and emerging drugs for acute myeloid leukemia
E. M. Stein, M. S. Tallman
Medicine, Hematology Oncology Division
Research output
:
Contribution to journal
›
Review article
›
peer-review
13
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Novel and emerging drugs for acute myeloid leukemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Chemotherapeutic Agent
100%
Drug
100%
Diseases
33%
Acute Promyelocytic Leukemia
16%
Leukemia Cell
16%
Exercise
16%
Overall Survival
16%
Hematologic Malignancy
16%
Rituximab
16%
Non-Hodgkin Lymphoma
16%
Imatinib
16%
Myeloid Leukemia
16%
Chronic Myelogenous Leukemia
16%
Lenalidomide
16%
Dying
16%
Cladribine
16%
Hairy Cell Leukemia
16%
Leukemia Survival
16%
Patient
16%
Physician
16%
Young Adult
16%
INIS
drugs
100%
myeloid leukemia
100%
patients
25%
leukemia
25%
genetics
12%
adults
12%
diseases
12%
mutations
12%
malignancies
12%
lymphomas
12%
refining
12%